GenMab Rallies After Raising Full-Year Guidance: Chart of the Day

[

INVESTOR CIRCLE](https://www.barrons.com/investor-circle)

GenMab’s technical indicators stand out among European biotech stocks

Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Continue reading this article with a Barron’s subscription

SUBSCRIBE NOW